Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data



Rating:

Share or cite this content

Citations should be made in the following way:
C. Vogelmeier (Marburg, Germany), M. Hechtner (Ingelheim, Germany), N. Picker (Wismar, Germany), A. Neitz (Ingelheim, Germany), P. Hofmann (Ingelheim, Germany), U. Maywald (Dresden, Germany), T. Wilke (Wismar, Germany), R. Buhl (Mainz, Germany). Comparison of initial drug treatment of incident COPD patients with German treatment guidelines. 2406

Member's Comments

No comment yet.

Related content which might interest you: Compliance of COPD patients to their treatment Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003 Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Implementation of the new regulations of SEPAR on the treatment of smoking in hospitalized patients Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations Year: 2019 Standards for the diagnosis and treatment of patients with COPD Source: Guideline 2004 Year: 2004 Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen Source: Eur Respir J 2003; 22: Suppl. 45, 375s Year: 2003 Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001 Treatment strategies for patients with complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Treatment patterns in the first four quarters following an incident COPD diagnosis in the UK Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Clinical and economic impact of inhaled corticosteroid withdrawal in Spanish COPD patients treated with triple therapy Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Adaptation rate between COPD treatment in clinical practice and guidelines recommendations Source: Eur Respir J 2007; 30: Suppl. 51, 779s Year: 2007 Treatment patterns in English asthma patients initiating multiple inhaler triple therapy: a cohort study Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Managing pediatric pneumonia by following guidelines to decrease the use of concurrent asthma medication. Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019 Impact of home hospitalization on treatment compliance in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001 Duration of therapy in hospitalised patients with CAP Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia Year: 2007 Prescriptions for treatment in patients with PCD: does clinical routine match recommendations? Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum Year: 2020 Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004